BeOne Medicines Ltd.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $87.5m $239.6m $712.9m $618.0m $1.4b $4.4b $3.9b $3.2b $2.6b $4.5b
Prepaid Expense and Other Assets, Current $6.2m $35.6m $81.9m $90.2m $160.0m $270.2m $216.6m $243.4m $192.9m $212.8m
Short-term Investments $597.9m $1.1b $364.7m $3.3b $2.2b $665.3m $2.6m
Inventory, Net $10.9m $16.2m $28.6m $89.3m $242.6m $282.3m $416.1m $495.0m $608.2m
Assets, Current $374.4m $913.5m $1.9b $1.2b $5.0b $7.6b $5.2b $4.2b $4.0b $6.2b
Property, Plant and Equipment, Net $26.0m $62.6m $157.1m $242.4m $357.7m $587.6m $845.9m $1.3b $1.6b $1.6b
Goodwill $109k $109k $109k $109k $109k $109k
Operating Lease, Right-of-Use Asset $45.1m $82.5m $90.6m $117.4m $110.0m $95.2m $139.3m $148.2m
Other Assets, Noncurrent $4.7m $42.9m $53.7m $68.5m $113.1m $163.0m $170.4m $125.4m $160.5m $102.4m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $29.4m $41.1m $70.9m $60.4m $483.1m $173.2m $358.0m $676.3m $865.1m
Accrued Liabilities, Current $163.6m $346.1m $558.1m $467.4m $693.7m $803.7m $1.1b
Assets $405.8m $1.0b $2.2b $1.6b $5.6b $8.6b $6.4b $5.8b $5.9b $8.2b
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $10.8m $13.9m $21.9m $24.0m $21.9m $17.6m $20.7m
Accounts Payable, Current $12.0m $69.8m $113.3m $122.5m $232.0m $262.4m $294.8m $315.1m $405.0m $479.0m
Operating Lease, Liability, Noncurrent $25.8m $29.4m $43.0m $34.5m $22.3m $44.3m $52.9m
Deferred Revenue, Current $12.2m
Deferred Revenue, Noncurrent $24.8m
Long-term Debt, Current Maturities $9.2m $8.7m $0 $335.0m $427.6m $329.0m $688.4m $851.5m $57.3m
Long-term Debt, Excluding Current Maturities $9.2m $40.8m $83.3m $183.6m $202.1m $209.1m $197.6m $166.5m $961.9m
Liabilities, Current $35.1m $150.0m $246.5m $310.3m $1.1b $1.6b $1.5b $1.8b $2.2b $1.8b
Deferred Income Tax Liabilities, Net $11.1m $10.5m $10.8m $14.2m $16.0m $16.5m $42.0m $53.2m
Other Liabilities, Noncurrent $564k $32.0m $38.9m $46.6m $57.4m $54.2m $46.1m $50.5m $66.7m $80.2m
Deferred Tax Liabilities, Net $16.0m $16.5m $42.0m $53.2m
Liabilities $52.9m $362.2m $496.0m $633.9m $1.7b $2.4b $2.0b $2.3b $2.6b $3.8b
Stockholders’ equity:
Common Stock, Value, Issued $52k $59k $77k $79k $118k $133k $135k $135k $138k $144k
Additional Paid in Capital $591.2m $1.0b $2.7b $2.9b $7.4b $11.2b $11.5b $11.6b $12.1b $12.8b
Retained Earnings (Accumulated Deficit) ($237.4m) ($330.5m) ($1.0b) ($2.0b) ($3.6b) ($5.0b) ($7.1b) ($8.0b) ($8.6b) ($8.3b)
Accumulated Other Comprehensive Income (Loss), Net of Tax ($946k) ($480k) $1.5m ($8.0m) $6.9m $17.9m ($77.4m) ($99.4m) ($149.0m) ($78.2m)
Stockholders' Equity Attributable to Parent $352.9m $669.8m $1.7b $962.2m $3.9b $6.2b $4.4b $3.5b $3.3b $4.4b
Stockholders' Equity Attributable to Noncontrolling Interest $14.4m $14.4m $16.1m $0
Liabilities and Equity $405.8m $1.0b $2.2b $1.6b $5.6b $8.6b $6.4b $5.8b $5.9b $8.2b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.